stella
beta
Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors — Stella
Recruiting
Back to Digestive System Neuroendocrine Tumor G1 trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
United States
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
View full record on ClinicalTrials.gov